Douglas Ingram

Sarepta Therapeutics

President and Chief Executive Officer

Overview

Annual data

2017

Non-Equity Incentive Plan$420,875
Option Awards$44,484,000
Salary$337,500
Stock Awards$11,607,750
Other$16,116
Total$56,866,241

In 2017, Douglas Ingram earned a total compensation of $56,866,241 as President and Chief Executive Officer at Sarepta Therapeutics, Inc..

Ingram received $44,484,000 in option awards, which accounts for 78.23% of total compensation.

Ingram also received $420,875 in non-equity incentive plan, $337,500 in salary, $11,607,750 in stock awards and $16,116 in other compensation.